organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 51ºÚÁϳԹÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
51ºÚÁϳԹÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Articles published in Journal of Alzheimers Disease & Parkinsonism have been cited by esteemed scholars and scientists all around the world. Journal of Alzheimers Disease & Parkinsonism has got h-index 25, which means every article in Journal of Alzheimers Disease & Parkinsonism has got 25 average citations.
Following are the list of articles that have cited the articles published in Journal of Alzheimers Disease & Parkinsonism.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|
Total published articles |
26 | 33 | 60 | 35 | 45 | 44 | 107 | 89 |
Conference proceedings |
0 | 33 | 0 | 0 | 82 | 213 | 118 | 158 |
Citations received as per Google Scholar, other indexing platforms and portals |
123 | 389 | 489 | 425 | 374 | 263 | 237 | 253 |
Journal total citations count | 4334 |
Journal impact factor | 2.04 |
Journal 5 years impact factor | 3.14 |
Journal cite score | 10.01 |
Journal h-index | 25 |
Journal h-index since 2019 | 22 |
![]() |
Atropa belladonna Expresses a microRNA (aba-miRNA-9497) Highly Homologous to Homo sapiens miRNA-378 (hsa-miRNA-378); both miRNAs target the 3?-Untranslated Region (3?-UTR) of the mRNA Encoding the Neurologically Relevant, Zinc-Finger Transcription Fact |
| | | |
![]() |
microRNA-based biomarkers in Alzheimer's disease (AD) |
| | | |
![]() |
Role of microRNA (miRNA) and viroids in lethal diseases of plants and animals. Potential contribution to human neurodegenerative disorders |
| | | |
![]() |
Alterations of Transcription of Genes Coding Anti-oxidative and Mitochondria-Related Proteins in Amyloid ? Toxicity: Relevance to Alzheimer's Disease |
| | | |
![]() |
Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma |
| | | |
![]() |
microRNA-34a (miRNA-34a) mediated down-regulation of the post-synaptic cytoskeletal element SHANK3 in sporadic Alzheimer's disease (AD) |
| | | |
![]() |
Addressing Alzheimer's disease (AD) neuropathology using anti-microRNA (AM) strategies |
| | | |
![]() |
Lipopolysaccharide-stimulated, NF-kB-, miRNA-146a- and miRNA-155-mediated molecular-genetic communication between the human gastrointestinal tract microbiome and the brain |
| | | |
![]() |
Microbiome-Derived Lipopolysaccharide (LPS) Selectively Inhibits Neurofilament Light Chain (NF-L) Gene Expression in Human Neuronal-Glial (HNG) Cells in Primary Culture |
| | | |
![]() |
Microbiome-mediated upregulation of microRNA-146a in sporadic Alzheimer's disease |
| | | |
![]() |
SARS-CoV-2 infectivity and neurological targets in the brain |
| | | |
![]() |
Bacteroidetes neurotoxins and inflammatory neurodegeneration |
| | | |
![]() |
MicroRNAs in Alzheimer's disease |
| | | |
![]() |
Potential effects of MSC-derived exosomes in neuroplasticity in Alzheimer's disease |
| | | |
![]() |
The role of ceramide and sphingosine-1-phosphate in Alzheimer's disease and other neurodegenerative disorders |
| | | |
![]() |
Treatment of Parkinson's Disease with Cognitive Impairment: Current Approaches and Future Directions |
| | | |
![]() |
Evaluation of the efficacy of physical therapy on cognitive decline at 6-month follow-up in Parkinson disease patients with mild cognitive impairment: a randomized controlled trial |
| | | |
![]() |
The Clinical Spectrum of Young Onset Dementia Points to Its Stochastic Origins |
| | | |
![]() |
Prion disease in Indigenous Australians |
| | | |
![]() |
Therapeutic Efficacy of Plasmalogens for Alzheimer’s Disease, Mild Cognitive Impairment, and Parkinson’s Disease in Conjunction with a New Hypothesis for the Etiology of Alzheimer’s Disease |
| | | |
Make the best use of Scientific Research and information from our 700 + peer reviewed, 51ºÚÁϳԹÏÍø Journals